Efficacy, long‐term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in JapanAtsushi Nakajima, Michael Camilleri, Per‐Göran Gillberg et al.|Neurogastroenterology & Motility|2019Cited by 33
Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipationAtsushi Nakajima, Michael Camilleri, Sonoko Ishizaki et al.|Journal of Gastroenterology and Hepatology|2022Cited by 26
Sa1715 ELOBIXIBAT, ILEAL BILE ACID TRANSPORTER INHIBITOR, INCREASES FECAL BILE ACIDS IN PATIENTS WITH CHRONIC CONSTIPATIONAtsushi Nakajima, Michael Camilleri, Sonoko Ishizaki et al.|Gastroenterology|2020Cited by 1